Literature DB >> 11348710

Vaccination against leprosy at Ben San Leprosy Centre, Ho Chi Minh City, Vietnam.

L V Truoc1, H M Ly, N K Thuy, D D Trach, C A Stanford, J L Stanford.   

Abstract

Three vaccines, BCG alone, BCG + 10(7) killed Mycobacterium vaccae and 10(8) killed M. vaccae alone, were studied in children living in close contact with leprosy. In the year before vaccination, 14/446 (3.1%) children had developed leprosy. Among those who were not vaccinated, 9/74 (12.2%) developed the disease in the first 4 years of the study and 5/65 (7.7%) developed the disease in the second 4 years. In comparison with this, among those vaccinated, 20/343 (5.8%) developed leprosy in the first 4 years and 5/323 (1.5%) developed leprosy in the second 4 years. This represents 52.5% protection in the first 4 years and 80.5% in the second 4 years. There were no significant differences in protection afforded by each of the three vaccines but the success of the killed preparation of M. vaccae is an important finding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348710     DOI: 10.1016/s0264-410x(01)00052-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

Review 1.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

Review 2.  The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.

Authors:  Anne Schoenmakers; Liesbeth Mieras; Teky Budiawan; Wim H van Brakel
Journal:  Res Rep Trop Med       Date:  2020-10-15

Review 3.  Vaccines for Leprosy and Tuberculosis: Opportunities for Shared Research, Development, and Application.

Authors:  Mariateresa Coppola; Susan J F van den Eeden; Naoko Robbins; Louis Wilson; Kees L M C Franken; Linda B Adams; Tom P Gillis; Tom H M Ottenhoff; Annemieke Geluk
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

Review 4.  Rapidly Growing Mycobacterium Species: The Long and Winding Road from Tuberculosis Vaccines to Potent Stress-Resilience Agents.

Authors:  Mattia Amoroso; Dominik Langgartner; Christopher A Lowry; Stefan O Reber
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.